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Abstract
Background: Hashimoto’s thyroiditis is the most important cause of hypothyroidism. It is a systemic disease that
can even affect the cardiovascular system, by accelerating the atherosclerotic process. Aim of this study was to
examine whether autoimmune thyroiditis has an effect on the intima-media thickness of the common carotid
artery (IMT-CCT), independently of the thyroid function and well-known cardiovascular risk factors. Hashimoto’s
thyroiditis is a systemic disease. The aim is to examine whether autoimmune thyroiditis and adiposity can effect
carotid IMT independently of thyroid hormones and cardiovascular risk factors.
Methods: A total of 104 obese women (BMI ≥ 25.0 kg/m
-2), with FT3 and FT4 serum levels in the normal range
and TSH levels < 4.5 μU/ml, were investigated. None of these patients was taking any kind of drug influencing
thyroid function. Measurements were made of the IMT-CCT, BMI, waist circumference, blood pressure levels, as well
as fasting TSH, FT3, FT4, anti-thyroid antibodies, insulin, fasting glycemia, triglycerides, total and HDL-cholesterol
serum concentrations.
Results: Of the 104 women, 30 (28.8%) were affected by autoimmune thyroiditis. Significantly higher values of IMT-
CCT (p < 0.05), TSH (p < 0.05), and triglycerides (p < 0.05) were obtained, and significantly lower values of FT4 (p <
0.05), in patients with Hashimoto’s thyroiditis as compared to those with a normal thyroid function. When
examining the whole group together, at multiple regression analysis Hashimoto’s thyroiditis maintained a positive
association with the IMT (p < 0.001), independently of age, hypertension, BMI, and the fasting serum levels of TSH,
FT3, FT4, insulin, fasting glycemia, triglycerides, total and HDL-cholesterol levels.
Conclusions: The present study shows that Hashimoto’s thyroiditis is associated to an increased IMT only in
overweight and obese, independently of the thyroid function, BMI and cardiovascular risk factors. These results
suggest that Hashimoto’s thyroiditis is a marker of evolution of the atherosclerosis if combined to adiposity.
Background
Although published data [1-3] clearly indicate that there
is a close relationship between even sub-clinical thyroid
dysfunction and an increased cardiovascular risk, the
underlying pathogenic process is still unknown.
Researchers have so far concentrated on demonstrating
the existence of the correlation and evaluating the
extent to which different degrees of thyroid dysfunction
increase the risk [4-6], but the study populations have
rarely been subdivided on the basis of the type of thyr-
oid disease. We believe that this second approach could
highlight the close relationships between the two organs,
allowing us to study the natural pathogenic mechanisms
underlying the impact of thyroid dysfunction on cardio-
vascular risk, rather than the effects of the secreted hor-
mones on the cardiovascular system in general [7].
Aim of this study was therefore to investigate whether
autoimmune Hashimoto’s thyroiditis increases the
intima-media thickness of the common carotid artery
(IMT-CCA), regardless of thyroid dysfunction or tradi-
tional cardiovascular risk factors.
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Subjects
A total of 104 overweight or obese women (BMI ≥ 25.0
kg/m
2) attending the Obesity Clinic of the Institute of
Internal Medicine, Endocrinology and Metabolic Dis-
ease, and the Emergency and Organ Transplant Depart-
ment of Bari University General Hospital, were enrolled
in the study, inclusion criteria being normal blood FT3
and FT4 concentrations, and TSH levels of <4.5 μU/ml.
Exclusion criteria were smoking habit, thyroid or other
known endocrine diseases, cardiovascular diseases (cor-
onary heart disease, arrhythmia, heart failure), vascular
brain diseases (stroke or a transient ischemic attack),
peripheral obstructive artery disease (claudicatio inter-
mittens, delayed or absent peripheral pulses), documen-
ted diabetes mellitus, a family or personal history of
severe dyslipidemia (triglyceride or total cholesterol
levels of >300 mg/dl), chronic liver disease, known kid-
ney disease or any other chronic severe disease. Women
taking any kind of medication other than anti-hyperten-
sive drugs, including b-blockers, were also excluded.
Of the 104 enrolled subjects, 30 had Hashimoto’s
thyroiditis (serum anti-thyroglobulin [Tg-Ab] and anti-
thyroid peroxidase antibodies [TPO-Ab]; the remaining
74 did not have positive serum auto-antibodies and
were therefore considered free of autoimmune thyroidi-
tis: these were taken as the controls. All patients had
serum fasting glucose levels of <126 mg/dl.
High blood pressure was present in 30% of the women
with, and 31% of those without autoimmune thyroiditis.
Arterial hypertension was diagnosed on the basis of pre-
existing treatment with antihypertensive drugs or the
criteria of the Third Report of the National Cholesterol
Education Program (NCEP) Expert Panel on Detection,
Evaluation, and Treatment of High Blood Cholesterol in
Adults (Adult Treatment Panel III) Final Report [8]: i.e.
systolic (SBP) and diastolic blood pressure (DBP) levels
of ≥130 and ≥85 mmHg. Blood pressure was evaluated
using a mercury sphygmomanometer with an appropri-
ate-sized cuff with the patients in sitting position, and
the average of three measurements was recorded.
Patients were instructed not to change their dietary
habits or practice more sport during the study period.
All patients and controls underwent to an ultrasound
assessment of their thyroid morphologies.
The study was approved by the Institutional Review Board
of Bari University General Hospital and carried out in accor-
dance with the principles of the Helsinki Declaration; all
patients gave informed consent before entering the study.
Anthropometric evaluations
The following anthropometric parameters were evalu-
ated: weight (kg), height (cm), body mass index (BMI)
expressed as weight in kilograms divided by the square
of height in metres (normal < 24.9 kg/m
2;o v e r w e i g h t
25-29.9 kg/m
2; obese ≥ 30 kg/m
2), and waist circumfer-
ence (cm).
Biochemistry analyses
Blood samples were taken fasting at 8.00 a.m., and used
to measure fasting glycemia (mg/dl), serum insulin
(μUI/ml; normal values [n.v.] 4.3-19.9 μU/ml), FT3 (pg/
ml; n.v. 2.2-4.2 pg/ml), FT4 (pg/ml; n.v. 8.1-17.1 pg/ml),
TSH (μUI/ml; n.v. 0.3-3.6 μU/ml), total cholesterol
(mg/dl), HDL cholesterol (mg/dl), triglycerides (mg/dl),
Tg-Ab (UI/ml; n.v. < 50 UI/ml) and TPO-Ab (UI/ml;
n.v. < 10 UI/ml). Blood glucose was measured using the
glucose-oxidase method (Sclavo, Siena, Italy); serum
insulin by radio-immune assay (Behring, Scoppito, Italy);
FT3, FT4 and TSH using a competitive photometric
method based on the solid phase antigen-linked techni-
que (LIASON FT3, LIASON FT4, LIASON TSH, Dia-
Sorin, Saluggi, Italy); total and HDL cholesterol, and
triglyceride levels using an enzymatic method (Boehrin-
ger Mannheim, Diagnostica Mannheim, Mannheim,
Germany); auto-antibodies by radio-immune assays (Tg-
Ab IRMA, Biocode, Sclessin, Belgium; TPO-Ab RIA,
Sorin Biomedica, Saluggia, Italy).
IMT-CCA ultrasonography
All patients underwent a two-dimensional echo-colour
Doppler examination of the carotid arteries using a
high-definition vascular echograph (Philips Sonos 5500
Ultrasound Scanner) and a 7.5 MHz linear electronic
probe. They were placed in supine position with their
neck in extension and rolled contralaterally by about
45°. The common carotid arteries were examined in the
long axis view using a lateral projection and 2.5× image
enlargement; bulbar dilation was considered to identify
the border between the distal common carotid artery
and carotid bulb [9-13]. None of the patients had ather-
osclerotic plaques, localised lesions ≥2m mt h i c k ,o r
stenoses.
The images were focused on the intima-media com-
plex of the arterial wall, frozen, and recorded on a
videotape. IMT was measured using a digital device
(Hewlett Packard, Borthell, Washington) according to
Pignoli [9]: i.e. the distance between the principal border
of one echogenic line and the principal border of a sec-
ond, separated by a relatively hypoechoic space ("the
double line pattern”). Three measurements were made 1
cm proximally from the carotid bulb on each side, and
the average of the six measurements was recorded. Each
scan was made by the same investigator, who was
blinded to the patients’ clinical history and
characteristics.
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The data are expressed as mean values ± standard
deviation except for the category-specific variables,
which are expressed in percentages. Between-group
differences were analysed using Student’st e s tf o ri n d e -
pendent samples; frequencies were compared using the
chi-squared exact test. The correlations between para-
meters were analysed using Pearson’s linear correlation
coefficient. The determinants of the independent IMT-
CCA variable were assessed by multiple regression ana-
lysis. All the analyses were made using STATISTICA
6.1 for Windows software (StatSoft Inc., Tulsa, OK,
USA), and p values of < 0.05 were considered statisti-
cally significant.
Results
Table 1 shows the anthropometric, biochemical and
IMT data on the population. There were no signifi-
cant between-group differences as to demographic
and anthropometric variables, but the patients with
Hashimoto’s thyroiditis had significantly higher IMT
(Fig. 1; Panel A), TSH (Fig. 1; Panel B) and triglycer-
ide levels, and significantly lower FT3 levels than the
controls.
Subclinical hypothyroidism (normal serum concentra-
tions of FT3 and FT4, and THS ≥ 3.6 μUI/ml) was
detected in three of the 74 patients without auto-
immune thyroiditis (4.05%) and seven of the 30 patients
with Hashimoto’ thyroiditis (23.3%).
Table 2 shows Pearson’s linear correlation coefficients
for simple regression analysis of the IMT with the other
parameters in the two groups and in the population as a
whole. In the population as a whole, IMT was signifi-
cantly and positively correlated with age, waist circum-
ference, fasting glycemia, total cholesterol, triglycerides
and hypertension; in the thyroiditis group, it was corre-
lated with age (Fig. 2; Panel A), fasting glycemia (Fig. 2;
Panel B), total cholesterol and triglycerides.
Table 3 shows the multiple regression analysis coeffi-
cients for the population as a whole, with the IMT as
the dependent variable and Hashimoto’s thyroiditis, age,
BMI (Model 1) or waist circumference (Model 2), fast-
ing glycemia, fasting insulin, FT3, FT4, TSH, total cho-
lesterol, HDL-cholesterol, triglycerides and hypertension
as independent variables. The two models showed a
good fit (R
2 = 0.41, P < 0.001 in each case) and the
IMT-CCA retained its independent and positive associa-
tion with age and the reference group (Hashimoto
Table 1 Characteristics of the studied population
Variables n = 104 HASHIMOTO (n = 30) CONTROLS (n = 74) P
Age (years) 39.8 ± 11.1
(18 - 66)
41.1 ± 11.9
(21 - 66)
39.2 ± 10.8
(18 - 61)
0.421
BMI (kg/m
2) 34.7 ± 6
(25 - 64.6)
34.5 ± 4.6
(27.2 - 45.1)
34.8 ± 6.5
(25 - 64.6)
0.847
Waist circumference (cm) 105.9 ± 12.8
(82 - 155)
105.6 ± 10.3
(88 - 132)
106 ± 13.7
(82 - 155)
0.903
Fasting glycemia (mg/dl) 92 ± 10.1
(70 - 118)
90.2 ± 9.5
(70 - 109)
92.7 ± 10.3
(70 - 118)
0.253
Fasting insulinemia (μIU/ml) 28.4 ± 17.9
(5 - 99)
29.5 ± 16.8
(6 - 72)
28 ± 18.4
(5 - 99)
0.688
TSH (μU/ml) 1.96 ± 1.05
(0.38 - 4.5)
2.47 ± 1.17
(0.5 - 4.31)
1.76 ± 0.94
(0.38 - 4.5)
0.002
FT3 (pg/ml) 3.25 ± 0.38
(2.3 - 4)
3.11 ± 0.4
(2.37 - 3.94)
3.31 ± 0.36
(2.3 - 4)
0.015
FT4 (pg/ml) 10.29 ± 1.2
(8 - 14.1)
10.26 ± 1.26
(8.44 - 13.3)
10.3 ± 1.19
(8 - 14.1)
0.869
Total cholesterol (mg/dL) 194.8 ± 38.3
(133 - 297)
201 ± 43.3
(133 - 297)
192.3 ± 36.1
(134 - 297)
0.299
HDL cholesterol (mg/dL) 49.1 ± 10.7
(25 - 85)
49 ± 9.7
(31 - 77)
49.1 ± 11.1
(25 - 85)
0.985
Triglycerides (mg/dL) 94.7 ± 43.1
(27 - 248)
114.4 ± 47.4
(47 - 248)
86.7 ± 38.8
(27 - 225)
0.003
IMT (mm) 0.65 ± 0.11
(0.42 - 0.89)
0.69 ± 0.1
(0.48 - 0.89)
0.64 ± 0.11
(0.42-0.89)
0.026
Systolic blood pressure (mmHg) 121.7 ± 13.2
(90-160)
120.6 ± 12.1
(105-150)
122.2 ± 13.7
(90-160)
0.573
Diastolic blood pressure (mmHg) 79.0 ± 8.6
(65-110)
76.8 ± 6.9
(65-90)
79.8 ± 9.14
(65-110)
0.098
Hypertension (%) 30.8 30 31.1 0.915
Mean values ± Standard Deviation (Range)
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the other variables was not significant. Moreover,
including in the analysis a dichotomic variables to take
in account the presence of TSH lower than 3.5, age and
Hashimoto remain positively associated with IMT in
model 1 (respectively, p < 0.001 and p = 0.048) and
model 2 (respectively, p < 0.001 and p = 0.049).
Discussion
Hashimoto’s thyroiditis is one of the most popular thyroid
disease. The diagnosis of Hashimoto’s thyroiditis was
defined on the basis of the presence of high serum thyroid
peroxidase antibody concentrations and of the ultrasound
examination, showing a hypoechogenic thyroid. Serum
thyroid peroxidase antibodies were considered high
whether their concentrations were higher than 40 UI/ml,
and they were high in 100 percent of patients with Hashi-
moto’s thyroiditis. Moreover, serum thyroglobulin antibo-
dies were considered high whether their concentrations
were higher than 125 UI/ml, and these antibodies were
high in less than 50 percent of the patients.
Just the hypoechogenic aspect of thyroid on ultra-
sound examination let us having a good instrumental
parameter in order to detect all patients affected by
Hashimoto’s thyroiditis
The importance of this study is that Hashimoto’ thyr-
oiditis per se increases the intima-media thickness of the
common carotid artery regardless of thyroid function.
Actually, Stamatelopoulos et al. [14] just underlined the
positive effects of Hashimoto’s thyroiditis on arterial
stiffness, regardless the intima-madia thickness. But only
overweight and obese women were enrolled in our
study and the differences in study group may partly
explain the different results between the Stamatelopou-
los and our study.
All of the subjects we included in our study had nor-
mal serum FT3 and FT4 levels and, although patients
with subclinical hypothyroidism were also included,
there was no linear correlation between IMT and serum
TSH levels. The correlation between IMT and Hashi-
moto thyroiditis is therefore independent of TSH and
thyroid hormone values.
Figure 1 Panel A: IMT values in Hashimoto patients and controls; Panel B: TSH values in Hashimoto patients and controls.
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hyperlipidemia were exclusion criteria [15], and the
other atherogenic factors such as abdominal obesity,
hypertension, fasting glycemia and insulin levels, and
lipidemia typifying the study population did not influ-
ence the association between auto-immune thyroiditis
and IMT, it can be said that Hashimoto’s thyroiditis
seems to be an independent cardiovascular risk factor. If
this is true, all patients with Hashimoto’s thyroiditis
(including euthyroid patients) may benefit from L-thyr-
oxin. Besides, Monzani et al. have clearly shown that six
months of thyroid-replacement therapy in patients with
hypothyroidism are sufficient to reduce carotid intima-
media thickness [16,17].
The pathogenetic mechanism underlying the increased
IMT is not clear, but some hypotheses can be made
[18-21]:
1) Although Hashimoto’s thyroiditis is related to the
IMT regardless of TSH and thyroid hormone levels,
we found that our patients with thyroiditis had
higher mean serum TSH and triglyceride levels, and
lower mean blood FT3 concentrations than the con-
trols. Furthermore, although only a minority of the
enrolled women suffered from subclinical hypothyr-
oidism, the percentage was higher among those with
auto-immune thyroiditis (23.3% vs 4.05%). For this
reason, a first hypothesis is that Hashimoto thyroidi-
tis, by reducing the thyroid function, is per se
responsible for increasing the IMT even in subjects
with normal FT3 and FT4 levels.
2) As expected, the IMT was directly correlated with
age, waist circumference, hypertension, fasting glyce-
mia, and total cholesterol and triglyceride levels,
thus confirming the findings of previously published
studies [21-23]. The correlation between the IMT
and fasting glycemia is particularly interesting
because none of the patients had fasting glycemia
levels of >110 mg/dl, which suggests a second
hypothesis, namely that defective glucose homeosta-
sis may also be per se a cardiovascular risk factor in
non-diabetic subjects [24-27].
We did not find a significant association between the
IMT and fasting insulin levels, although high insulin
concentrations are considered a surrogate marker of
insulin resistance [15]. However, this is in line with
the findings of previous studies that have not
demonstrated a clear relationship between insulin
concentrations and the angiographically-assessed
severity of coronary disease [28,29]. Nevertheless, it
is possible that determining fasting insulin concen-
trations by means of an immuno-assay is only an
indirect measure of insulin resistance and cannot be
compared with measures of in vivo hormone sensi-
tivity indicating an independent association between
insulin resistance and the IMT-CCA.
3) Finally, Hashimoto’s thyroiditis is an auto-
immune disease, and it is well-known that a number
of auto-immune diseases are associated with arteritis,
accelerated atherosclerosis progression and an
increased cardiovascular risk (rheumatoid arthritis,
systemic lupus erythematosus, antiphospholipid anti-
body syndrome...) [30], and so it cannot be excluded
that Hashimoto’s thyroiditis may in itself be respon-
sible for auto-immune or inflammation-based arteri-
tis. We have no firm evidence supporting such a
hypothesis, but it could be an interesting issue to be
addressed in future research. Such a consideration
come from even from Taddei and al. study [7] in
which they demonstrate the endothelial dysfunction
coming from Hashimoto’s thyroiditis, independently
from others cardiovascular risk factors and rather
associated with the autoimmune process by itself.
For this reason Taddei et al. pointed out the benefi-
cial use of anti-inflammatory drugs in reducing
Table 2 Pearson’s correlation coefficients for simple
linear regression between the IMT and all the other
parameters in the Hashimoto patients, controls and the
population as a whole
Hashimoto
(n = 30)
Controls
(n = 74)
Total
(n = 104)
Age 0.60 ***
p < 0.001
0.50 ***
p < 0.001
0.53 ***
p < 0.001
BMI -0.10
p = 0.613
0.10
p = 0.382
0.06
p = 0.572
Waist circumference 0.20
p = 0.294
0.22
p = 0.062
0.21*
p = 0.037
Fasting glycemia 0.62 ***
p < 0.001
0.25 *
p = 0.030
0.31 **
p = 0.001
Fasting insulinemia -0.08
p = 0.660
0.05
p = 0.649
0.03
p = 0.779
TSH 0.13
p = 0.481
-0.05
p = 0.693
0.08
p = 0.445
FT3 -0.01
p = 0.951
0.02
p = 0.841
-0.04
p = 0.694
FT4 0.03
p = 0.876
-0.01
p = 0.941
0
p = 0.987
Total cholesterol 0.46 *
p = 0.011
0.26 *
p = 0.025
0.33 **
p = 0.001
HDL cholesterol 0.00
p = 0.989
-0.07
p = 0.570
-0.05
p = 0.618
Triglycerides 0.52 **
p = 0.003
0.23
p = 0.051
0.36 ***
p < 0.001
Systolic blood pressure 0.48**
P = 0.008
0.34**
P = 0.003
0.35***
P < 0.001
Diastolic blood pressure 0.21
P = 0.270
0.23*
P = 0.046
0.18
P = 0.064
Hypertension 0.23
p = 0.231
0.28 *
p = 0.016
0.26 **
p = 0.009
* P < 0.05; ** P < 0.01; *** P < 0.001
Ciccone et al. BMC Cardiovascular Disorders 2010, 10:22
http://www.biomedcentral.com/1471-2261/10/22
Page 5 of 8impaired endothelial function in patients with such a
disease.
4) Besides, even though TSH levels were higher in
the group with Hashimoto’s thyroiditis, BMI and
waist circumference were not different between thyr-
oiditis and control groups, thus possibly excluding
that higher TSH in the thyroiditis group is due to
obesity itself.
Conclusions
In conclusion, our findings show that Hashimoto’s thyroi-
ditis is associated with increased arterial wall IMT
Figure 2 Panel A: Simple linear correlation of age and IMT in Hashimoto patients and controls; Panel B: Simple linear correlation
between fasting glycemia levels and IMT in Hashimoto patients and controls.
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cular risk factors, such as abdominal obesity, hypertension,
fasting glycemia, serum insulin and lipid levels. This seems
to suggest that auto-immune thyroiditis is in itself a mar-
ker of evolution of the atherosclerotic process, particularly
in overweight and obese subjects. It seems due to the link-
age between the auto-immune process end the endocrinal
state consequence to overweight and obesity.
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